Prenetics Global Limited

NASDAQ:PRE

Medical - Diagnostics & Research

Healthcare
$10.35 +2.19%

+$0.43 today

Market cap
$185.61M
Beta
0.24
P/E (TTM)
-4.9
EPS (TTM)
-$4.18
52W Low $7.18High $23.63

Volume 1.58M

Average 0.22M

PRE Pre-Tax Margin

Income before tax as a percentage of revenue.

Prenetics Global LimitedNASDAQ: PRE

Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026

Pre-tax margin narrows to -76.0%

Pre-tax margin was -76.0% in Q1 FY2026, down 12.0 pp from a year earlier. On a trailing-twelve-month basis it was -64.5%, up 78.3 pp year over year. Over 3 fiscal years it widened by 1676.2 pp.

Context

  • Pre-tax margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-76.0%+1.7 pp QoQ
Last fiscal yearDec 2025
-39.2%+149.2 pp YoY
LTMMar 2026
-64.5%+78.3 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-12.0 pp——
1 year+149.2 pp——
3 years+1676.2 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
-39.2%
Year-over-year change
+149.2pp

Pre-Tax Margin vs competitors

How PRE compares with its peers on the latest reported figures

  • PRE's LTM Mar 2026 pre-tax margin of -64.5% is the 5th highest of the 11 companies compared; the peer median is -93.0%.
  • Its year-over-year change of +78.3 pp is the 2nd highest of 11, against a peer median of +2.8 pp.
  • Over three fiscal years its change of +1676.2 pp compares with a peer median of -25.7 pp.
PRE Competitors Peer median
Pre-Tax Margin for PRE and competitors
Company Period LTM level YoY 3-year change
ATLNAtlantic International Corp.LTM Dec 2025-13.6% +15.8 pp-13.1 pp
STIMNeuronetics, Inc.LTM Mar 2026-24.6% +29.8 pp+30.9 pp
CDXSCodexis, Inc.LTM Mar 2026-40.9% +108.5 pp-38.4 pp
TLSITriSalus Life Sciences, Inc.LTM Mar 2026-60.8% +23.8 pp+293.7 pp
PREPrenetics Global LimitedLTM Mar 2026-64.5% +78.3 pp+1676.2 pp
OSUROraSure Technologies, Inc.LTM Mar 2026-64.8% -45.9 pp-54.1 pp
MXCTMaxCyte, Inc.LTM Mar 2026-121.2% -10.2 pp-81.9 pp
PROFProfound Medical Corp.LTM Mar 2026-206.5% +64.8 pp+161.9 pp
SGMOSangamo Therapeutics, Inc.LTM Mar 2026-358.9% -234.0 pp-139.9 pp
IMDXInsight Molecular Diagnostics Inc.LTM Mar 2026-2454.6% -940.1 pp+704.3 pp
ARMPArmata Pharmaceuticals, Inc.LTM Mar 2026-9554.2% -9545.2 pp-2873.8 pp
Peer median (excluding PRE) -93.0%+2.8 pp-25.7 pp

Competitors are the stored peer set for PRE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue12.53M13.16M21.74M30.62M92.39M
Cost of Revenue8.93M9.55M12.91M15.22M43.6M
Gross Profit3.6M3.62M8.83M15.4M48.79M
Gross Margin28.7%27.5%40.6%50.3%52.8%
Research & Development6.39M5.99M11.66M10.92M5.13M
Selling, General & Admin53.67M64.08M49.68M55.37M79.8M
Operating Expenses60.26M69.64M60.74M63.54M86.92M
Depreciation & Amortization7.35M7.54M7.79M5.93M3.78M
EBITDA(209.16M)(218.04M)(47.9M)(51.57M)(32.19M)
EBITDA Margin-1668.9%-1656.3%-220.3%-168.4%-34.8%
Operating Income(56.66M)(66.02M)(51.91M)(48.14M)(38.13M)
Operating Margin-452.1%-501.5%-238.7%-157.2%-41.3%
Interest Income201472K3.92M2.04M1.04M
Interest Expense42.23K242K119.66K203K241K
Other Income / Expenses(159.89M)(159.8M)(4.76M)(9.56M)1.92M
Income Before Tax(216.55M)(225.82M)(56.67M)(57.7M)(36.21M)
Pre-Tax Margin-1727.9%-1715.4%-260.6%-188.4%-39.2%
Income Tax Expense2.57M(245K)(269.36K)(7.87M)34K
Net Income(174.01M)(190.45M)(62.72M)(46.3M)(37.71M)
Net Margin-1388.4%-1446.8%-288.5%-151.2%-40.8%
EPS (Basic)(47.04)(37.57)(5.58)(3.64)(2.68)
EPS (Diluted)(47.04)(37.57)(5.58)(3.64)(2.68)
Weighted Avg Shares3.7M5.07M11.25M12.71M14.05M
Weighted Avg Shares (Diluted)3.7M5.07M11.25M12.71M14.05M

Prenetics Global Limited

NASDAQ:PRE

Intrinsic Alpha fair value

Locked

Current Price

$10.35

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.